Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00568425 · ClinicalTrials.gov registry record
QOL & Functional Outcomes After Combined Modality Tx for Anal CA: Comparison of Conventional vs IMRT
A clinical trial, sponsored by Stanford University.
- Terminated
- Registry status
- 10
- Enrollment target
NCT00568425: Clinical Trial study, sponsored by Stanford University.
NCT00568425 is a clinical trial that was terminated before completion, run by Stanford University. The registered enrollment target is 10 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00568425 was terminated before completion, sponsored by Stanford University.
- TERMINATED
- Registry status
- 10 participants
- Enrollment target
Study Summary
The purpose of this study is show that intensity-modulated radiotherapy (IMRT), as compared with conventional radiotherapy, improves the precision of tumor targeting and reduces the acute and late effects of radiation toxicity when used to treat anal cancer. Results from this work will provide a basis for incorporating the use of IMRT to treat anal cancer in future treatment protocols.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2005-09 |
| Est. Completion | 2009-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00568425
The ClinicalTrials.gov registry entry for NCT00568425 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00568425 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00568425 about?
NCT00568425 is a clinical study titled "QOL & Functional Outcomes After Combined Modality Tx for Anal CA: Comparison of Conventional vs IMRT". The purpose of this study is show that intensity-modulated radiotherapy (IMRT), as compared with conventional radiotherapy, improves the precision of tumor targeting and reduces the acute and late effects of radiation toxicity when used to treat anal cancer. Results from this work will provide a bas...
What is the current status of trial NCT00568425?
This trial is currently terminated. The enrollment target is 10 participants. The study started on 2005-09. Estimated completion is 2009-09.
Who is sponsoring clinical trial NCT00568425?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.